Effect of yoghurt containing Bifidobacterium lactis Bb12® on faecal excretion of secretory immunoglobulin A an
User Rating: Be the first one!
Author: Kabeerdoss, Jayakanthan, Shobana Devi, R, Regina Mary, R, Prabhavathi, D, Vidya, R, Mechenro, John, Mahendri, NV, Pugazhendhi, Srinivasan, Ramakrishna, Balakrishnan S
Added by: jake
Added Date: 2014-10-25
Language: eng
ISSN Number: 1475-2891 (Electronic)
Pages Count: 600
PPI Count: 600
PDF Count: 1
Total Size: 7.99 MB
PDF Size: 714.11 KB
Extensions: djvu, gif, pdf, gz, zip, torrent
Volume: 10
Contributor: BioMed Central
Downloads: 84
Views: 134
Total Files: 14
Media Type: texts
Total Files: 5
Description
This article is from Nutrition Journal, volume 10.
Abstract
Background: Probiotics are used to provide health benefits. The present study tested the effect of a probiotic yoghurt on faecal output of beta-defensin and immunoglobulin A in a group of young healthy women eating a defined diet. Findings: 26 women aged 18-21 (median 19) years residing in a hostel were given 200 ml normal yoghurt every day for a week, followed by probiotic yoghurt containing Bifidobacterium lactis Bb12® (109 in 200 ml) for three weeks, followed again by normal yoghurt for four weeks. Stool samples were collected at 0, 4 and 8 weeks and assayed for immunoglobulin A and human beta-defensin-2 by ELISA. All participants tolerated both normal and probiotic yoghurt well. Human beta-defensin-2 levels in faeces were not altered during the course of the study. On the other hand, compared to the basal sample, faecal IgA increased during probiotic feeding (P = 0.0184) and returned to normal after cessation of probiotic yoghurt intake. Conclusions: Bifidobacterium lactis Bb12® increased secretory IgA output in faeces. This property may explain the ability of probiotics to prevent gastrointestinal and lower respiratory tract infections.You May Also Like
We will be happy to hear your thoughts